๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐ซ๐ฒ๐ฌ๐ญ๐š๐ฅ๐ฅ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง & ๐‚๐ซ๐ฒ๐ฌ๐ญ๐š๐ฅ๐ฅ๐จ๐ ๐ซ๐š๐ฉ๐ก๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž & ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“) ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ƒ- https://lnkd.in/dXyUTRBM The North American protein crystallization & crystallography market is expected to show robust revenue growth from 2020 to 2035, rising from USD 700 million in 2020 to an estimated USD 2,100 million by 2035. The sustained expansion is propelled by technological advancements, increasing R&D investments, greater adoption in drug discovery, and evolving applications in diagnostics and industrial research. The compound annual growth rate reflects an upward market trajectory, signifying expanding opportunities for suppliers, research institutions, and biopharma companies across the region. Key Drivers Advancement in automation & high-throughput screening instruments, as demonstrated by Thermo Fisher Scientific’s recent launch of integrated robotics for crystallization in June 2024. Growing demand for protein structure-based drug discovery, supported by PerkinElmer’s expanded offerings tailored to pharmaceutical R&D labs in 2025. Key Trends Accelerated adoption of cryo-electron microscopy technology, with Rigaku unveiling its upgraded cryo-EM instrument line in July 2024. Increasing collaborations among academic, government, and industry players for structural biology initiatives, showcased by GE Healthcare’s strategic partnerships with top North American research institutes. Market Insights & Segmentation Type (Reagents, Instruments, Automation & Robotics, Software & Services), Application (Drug Discovery, Structural Biology, Disease Diagnostics, Industrial Applications), Distribution Channels (Online, Offline), Technology (X-ray Crystallography, NMR Spectroscopy, Cryo-Electron Microscopy, Microfluidics), Organization Size (Small, Medium, Large) Key Market Companies Bruker Corporation, Rigaku Corporation, Formulatrix Inc., Hampton Research, Molecular Dimensions, Jena Bioscience GmbH, Anton Paar GmbH, Oxford Instruments plc, GE Healthcare, Thermo Fisher Scientific Inc., Tecan Group Ltd., Agilent Technologies Inc., PerkinElmer Inc., Art Robbins Instruments, Bio-Rad Laboratories Inc. ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ- https://lnkd.in/dRmMpMRX



๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ƒ-
https://lnkd.in/dXyUTRBM

The North American protein crystallization & crystallography market is expected to show robust revenue growth from 2020 to 2035, rising from USD 700 million in 2020 to an estimated USD 2,100 million by 2035. The sustained expansion is propelled by technological advancements, increasing R&D investments, greater adoption in drug discovery, and evolving applications in diagnostics and industrial research. The compound annual growth rate reflects an upward market trajectory, signifying expanding opportunities for suppliers, research institutions, and biopharma companies across the region.

Key Drivers
Advancement in automation & high-throughput screening instruments, as demonstrated by Thermo Fisher Scientific’s recent launch of integrated robotics for crystallization in June 2024.
Growing demand for protein structure-based drug discovery, supported by PerkinElmer’s expanded offerings tailored to pharmaceutical R&D labs in 2025.

Key Trends
Accelerated adoption of cryo-electron microscopy technology, with Rigaku unveiling its upgraded cryo-EM instrument line in July 2024.
Increasing collaborations among academic, government, and industry players for structural biology initiatives, showcased by GE Healthcare’s strategic partnerships with top North American research institutes.

Market Insights & Segmentation
Type (Reagents, Instruments, Automation & Robotics, Software & Services),
Application (Drug Discovery, Structural Biology, Disease Diagnostics, Industrial Applications),
Distribution Channels (Online, Offline), Technology (X-ray Crystallography, NMR Spectroscopy, Cryo-Electron Microscopy, Microfluidics),
Organization Size (Small, Medium, Large)

Key Market Companies
Bruker Corporation, Rigaku Corporation, Formulatrix Inc., Hampton Research, Molecular Dimensions, Jena Bioscience GmbH, Anton Paar GmbH, Oxford Instruments plc, GE Healthcare, Thermo Fisher Scientific Inc., Tecan Group Ltd., Agilent Technologies Inc., PerkinElmer Inc., Art Robbins Instruments, Bio-Rad Laboratories Inc.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ- https://lnkd.in/dRmMpMRX

Comments

Popular posts from this blog

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐๐ž๐ฐ๐›๐จ๐ซ๐ง ๐’๐œ๐ซ๐ž๐ž๐ง๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž & ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“)

๐”๐’ ๐’๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐š๐ฅ ๐€๐๐ก๐ž๐ฌ๐ข๐ฏ๐ž ๐“๐š๐ฉ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“ - ๐’๐–๐Ž๐“ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ

Electronic Expansion Valves (EEV) Industry - Strategy Analysis